TheEdgeResearch
Home / Stocks / HSTC

HST Global, Inc. (HSTC)

OTC Healthcare Biotechnology
$0.20 ▲ +0.00%
Market Cap
$59.8M
Sector
Healthcare
Industry
Biotechnology
Beta
-1.24
52-Wk Range
0.063-1
CEO
Michael Fortkort
Country
US
Currency
USD

HST Global, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Virginia Beach, VA, US. The stock last traded at $0.20, up 0.00% on the session, giving a market capitalisation of $59.8M. On trailing twelve-month figures it carries a trailing P/E of -153.85, a net margin of -35.6%. Its beta of -1.24 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-153.85
Price / Sales
68.14
Price / Book
4.69
EV / EBITDA
-1077.29
Gross margin
82.0%
Operating margin
-24.4%
Net margin
-35.6%
Return on equity
—
Debt / equity
0.07
Current ratio
0.64
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2002-06-24
Headquarters
Virginia Beach, VA, US
About HST Global, Inc.

HST Global, Inc. operates in the healthcare, software and media, and transportation industries. It offers Qwyit, a cryptographic protocol. HST Global, Inc. is based in Virginia Beach, Virginia.

Comparable companies

HST Global, Inc. is most often compared with the following Healthcare names:

ARQQGTIISURGWHEN
More research on HSTC
HSTC technical analysis HSTC TheEdge Score Compare against peers
Open full interactive analysis & DCF →